These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9328472)

  • 21. Sequencing of exons 16 and 17 of the beta-amyloid precursor protein gene in 14 families with early onset Alzheimer's disease fails to reveal mutations in the beta-amyloid sequence.
    Crawford F; Hardy J; Mullan M; Goate A; Hughes D; Fidani L; Roques P; Rossor M; Chartier-Harlin MC
    Neurosci Lett; 1991 Nov; 133(1):1-2. PubMed ID: 1791986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic risk and transcriptional variability of amyloid precursor protein in Alzheimer's disease.
    Brouwers N; Sleegers K; Engelborghs S; Bogaerts V; Serneels S; Kamali K; Corsmit E; De Leenheir E; Martin JJ; De Deyn PP; Van Broeckhoven C; Theuns J
    Brain; 2006 Nov; 129(Pt 11):2984-91. PubMed ID: 16931535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of amyloid beta protein precursor processing as a means of retarding progression of Alzheimer's disease.
    Wagner SL; Munoz B
    J Clin Invest; 1999 Nov; 104(10):1329-32. PubMed ID: 10562291
    [No Abstract]   [Full Text] [Related]  

  • 24. A causal role for amyloid in Alzheimer's disease: the end of the beginning.
    Rosenberg RN
    Neurology; 1993 May; 43(5):851-6. PubMed ID: 8492934
    [No Abstract]   [Full Text] [Related]  

  • 25. [Screening for mutations of the precursor of beta-amyloid protein in early forms of Alzheimer disease. French Study Group of Alzheimer Disease].
    Rev Neurol (Paris); 1993; 149(10):528-31. PubMed ID: 8023065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical, neuropathologic, and biochemical profile of the amyloid precursor protein I716F mutation.
    Guardia-Laguarta C; Pera M; Clarimón J; Molinuevo JL; Sánchez-Valle R; Lladó A; Coma M; Gómez-Isla T; Blesa R; Ferrer I; Lleó A
    J Neuropathol Exp Neurol; 2010 Jan; 69(1):53-9. PubMed ID: 20010303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The molecular genetics of Alzheimer's disease.
    Mullan M; Crawford F
    Mol Neurobiol; 1994; 9(1-3):15-22. PubMed ID: 7888092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GxxxG motifs within the amyloid precursor protein transmembrane sequence are critical for the etiology of Abeta42.
    Munter LM; Voigt P; Harmeier A; Kaden D; Gottschalk KE; Weise C; Pipkorn R; Schaefer M; Langosch D; Multhaup G
    EMBO J; 2007 Mar; 26(6):1702-12. PubMed ID: 17332749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment.
    Wiley JC; Hudson M; Kanning KC; Schecterson LC; Bothwell M
    J Neurochem; 2005 Sep; 94(5):1189-201. PubMed ID: 15992373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The AAP and PS1/2 mutations linked to early onset familial Alzheimer's disease increase the extracellular concentration and A beta 1-42 (43)].
    Younkin SG
    Rinsho Shinkeigaku; 1997 Dec; 37(12):1099. PubMed ID: 9577655
    [No Abstract]   [Full Text] [Related]  

  • 31. Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Abeta 42 production.
    Moehlmann T; Winkler E; Xia X; Edbauer D; Murrell J; Capell A; Kaether C; Zheng H; Ghetti B; Haass C; Steiner H
    Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8025-30. PubMed ID: 12048239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The significance of the Swedish APP670/671 mutation for the development of Alzheimer's disease amyloidosis.
    Johnston J; O'Neill C; Lannfelt L; Winblad B; Cowburn RF
    Neurochem Int; 1994 Jul; 25(1):73-80. PubMed ID: 7950974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low Florbetapir PET Uptake and Normal Aβ1-42 Cerebrospinal Fluid in an APP Ala713Thr Mutation Carrier.
    Lombardi G; Berti V; Tedde A; Bagnoli S; Piaceri I; Polito C; Lucidi G; Ferrari C; Ginestroni A; Moretti M; Pupi A; Nacmias B; Sorbi S
    J Alzheimers Dis; 2017; 57(3):697-703. PubMed ID: 28304299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study on expression of PS1 in APP-PS1 double gene stably transfected cell lines and its relation to gamma-secretase].
    Liang P; Pan YX; Zhao XM; Du HZ; Zhang JM
    Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):297-301. PubMed ID: 16181553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [APP, the causal gene for Alzheimer's disease].
    Tamaoka A; Kametani F
    Tanpakushitsu Kakusan Koso; 1996 Aug; 41(10):1453-9. PubMed ID: 8741396
    [No Abstract]   [Full Text] [Related]  

  • 36. Reduced β-amyloid pathology in an APP transgenic mouse model of Alzheimer's disease lacking functional B and T cells.
    Späni C; Suter T; Derungs R; Ferretti MT; Welt T; Wirth F; Gericke C; Nitsch RM; Kulic L
    Acta Neuropathol Commun; 2015 Nov; 3():71. PubMed ID: 26558367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene.
    Mann DM; Iwatsubo T; Ihara Y; Cairns NJ; Lantos PL; Bogdanovic N; Lannfelt L; Winblad B; Maat-Schieman ML; Rossor MN
    Am J Pathol; 1996 Apr; 148(4):1257-66. PubMed ID: 8644866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased plasma β-amyloid in the Alzheimer's disease APP A673T variant carriers.
    Martiskainen H; Herukka SK; Stančáková A; Paananen J; Soininen H; Kuusisto J; Laakso M; Hiltunen M
    Ann Neurol; 2017 Jul; 82(1):128-132. PubMed ID: 28556232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Familial Alzheimer's disease by beta-amyloid protein precursor (beta APP) mutations].
    Okochi M; Takeda M
    Nihon Rinsho; 2004 Jan; 62 Suppl():86-9. PubMed ID: 15011326
    [No Abstract]   [Full Text] [Related]  

  • 40. Screening for mutations in the open reading frame and promoter of the beta-amyloid precursor protein gene in familial Alzheimer's disease: identification of a further family with APP717 Val-->Ile.
    Fidani L; Rooke K; Chartier-Harlin MC; Hughes D; Tanzi R; Mullan M; Roques P; Rossor M; Hardy J; Goate A
    Hum Mol Genet; 1992 Jun; 1(3):165-8. PubMed ID: 1303172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.